GoodRx Holdings (GDRX) Cash from Operations (2019 - 2026)

GoodRx Holdings has disclosed Cash from Operations across 8 years of filings, most recently posting 11838000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 11838000.0, up 25.76% year-over-year; the trailing twelve-month figure through Mar 2026 was 170329000.0 (up 13.01% YoY), and the FY2025 annual result was 167904000.0, down 8.69% from the prior year.
• Cash from Operations came in at 11838000.0 for Q1 2026 at GoodRx Holdings, down from 32888000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 86862000.0 in Q3 2024 to a low of 9413000.0 in Q1 2025.
• The 5-year median for Cash from Operations is 32888000.0 (2025), against an average of 38159176.47.
• Peak annual rise in Cash from Operations reached 411.08% in 2025, while the deepest fall reached 77.9% in 2025.
• GoodRx Holdings' Cash from Operations stood at 31879000.0 in 2022, then slumped by 50.22% to 15868000.0 in 2023, then jumped by 181.97% to 44743000.0 in 2024, then fell by 26.5% to 32888000.0 in 2025, then plunged by 64.01% to 11838000.0 in 2026.
• The last three Cash from Operations figures came in at 11838000.0 (Q1 2026), 32888000.0 (Q4 2025), and 76023000.0 (Q3 2025), per Business Quant data.